Medical care of breastfeeding women, initial treatment, Centre de Preuves en Dermatologie

Guidelines classic scabies: in children < 15kg, pregnant or breastfeeding women Updated on Jan 24

Responsibility

The information provided by this website comes from sources deemed reliable. However, the Société Française de Dermatologie recommends that the user ensure the validity of this information. Some may prove to be erroneous or be subject to typos or display errors.

The use of this data is under the sole responsibility of the user. The Société Française de Dermatologie cannot be blamed for a misinterpretation of the data provided by the site, or in the event of erroneous information. This decision tree and all the contents of this site have been developed in the context of updated data from science according to the HAS methodology, expert opinions and reviewers of the various documents and in the context of the French healthcare system.

I have read and accept the general conditions of use of this website

Breast-feeding woman with classic Scabies

Back to decision-making tree Print last updated on 29/08/2024

Initial treatment

Therapeutic proposal

or	Permethrin 5% cream	---
	10% Benzyl Benzoate	Repeat a second time between the 8^th and 14^th day
	Ivermectin oral 200µg/kg off-label use

Ivermectin's case

The treatment of breastfeeding women in contact with a case of scabies (primary circle) is recommended according to recommendations above, favoring Ivermectin.

Ivermectin is preferred in cases of poor skin condition, particularly mammary involvement.

Other considerations

For the use of Ivermectin, an infectious disease advice is required if stay in tropical zone exposes to risk of loasis.

Strategy for Breast-feeding Contact cases women

The treatment for breastfeeding women in contact with a case of scabies (primary circle) is recommended according to the previous guidelines, with a preference for Ivermectin.

Was this article helpful to you?
Your opinion counts!

This notice will not be published on this site, but only sent to the publication management. Your email will only be used to reply to you if we deem it necessary. No response will be sent to any request for medical advice via this form.